News

The company expects to convert manufacturing capacity at the facility to allow future production of the once-weekly GLP-1 analogue type 2 diabetes therapy. Operations at the converted plant

As per the agreement, Astellas’ ASP7035, which completed a phase I study and is yet to enter into phase IIa-study, will be licensed to Tacurion. Tacurion will be

ALX-0962 comprises anti-IgE Nanobody with dual mode of action and a serum albumin binding Nanobody for in vivo plasma half-life extension. Ablynx chairman and CEO Dr Edwin Moses

The partnership will enable CML to increase its market share in the specialized CRO custom bioanalytical testing space, currently serviced by its subsidiary, Hemostasis Reference Laboratory. Expected to

In February 2013, the Agency had granted Fast Track status for ceftolozane/tazobactam in Complicated Intra-Abdominal Infections (cIAI). Cubist Pharmaceuticals Chief Scientific Officer Steven Gilman said that the incentive,

The new venture, Redx Anti-Infectives, will create 119 high value science jobs at the site, establishing a new team to develop drugs combatting resistance to antibiotics and new

Powered by CVS/pharmacy and accessible through Viagra.com, the site offers men with erectile dysfunction (ED) an opportunity to purchase Viagra online (with a valid prescription) from a trusted

Initially, the collaboration will focus on one program, but has the potential to encompass multiple targets. As per the agreement, Concert will receive an upfront payment of more

The funding will move the early-stage research to the next level, to find new medicines for diseases such as TB, malaria, Leishmaniasis and sleeping sickness. Scientists across the